San Francisco, 10 March 2030: The Report Direct-to-Consumer Genetic Testing Market Size, Share & Trends Analysis Report By Test Type (Nutrigenomics, Carrier), By Technology (Whole Genome Sequencing), By Distribution Channel, By Region, And Segment Forecasts, 2024 - 2030

The global direct-to-consumer genetic testing market size is expected to reach USD 8.82 billion by 2030, registering a CAGR of 24.4% during the forecast period, according to a new report by Grand View Research, Inc. The major drivers of market growth include increasing awareness about the potential benefits of genetic testing, growing demand for personalized medicine, and decreasing the cost of genomic sequencing. Moreover, the number of companies offering direct-to-consumer (DTC) genetic testing services has increased, offering consumers a wider range of options.

The marketplace is moderately fragmented, with a large number of medium and large-sized companies accounting for the majority revenue of the market. These entities are undertaking various strategic initiatives to strengthen their marketplace presence. For instance, in August 2021, Ancestry declared that it acquired a leading French genealogy company, Geneanet.

The market has significantly grown in the past few years due to the growing interest of consumers and healthcare providers in personalized genetic analysis. This is majorly due to the growing concerns about sedentary lifestyle and poor diet-related illness among the global population. Companies are undertaking strategic initiatives to increase awareness among consumers about the benefits of genealogy examination. This, in turn, has developed DTC testing, one of the key applications of the consumer genomics field, to capture the wide interest of clinicians and customers.

Millions of users have used services provided by consumer genomics companies to learn about their ancestry, family tree, and risk of inherited disorders. DNA database of Ancestry DNA includes data of around three million people. Recently, AncestryDNA announced that it has sold more than 3.5 million DNA test kits, whereas its competitor 23andMe reported 1 million members. In addition, around 15% (nearly 2.5 million subscribers) of total DNA kit customers are Ancestry subscribers who pay around USD 20.0 for access to Ancestry's research data and tools per month.

The COVID-19 pandemic had a significant impact on the DTC genetic testing market. There was a notable demand for at-home genetic testing during the pandemic. However, the at-home segment declined as the pandemic withered.

Request sample report of Direct-to-Consumer Genetic Testing Market@ https://www.grandviewresearch.com/industry-analysis/direct-to-consumer-genetic-testing-market-report/request/rs1

Direct-to-consumer (DTC) genetic testing has become increasingly popular in recent years, as advancements in technology have made genealogy screening more accessible and affordable. Additionally, the rising interest in pharmacogenetics is anticipated to expand the DTC gene testing space.

In recent years, there has been a significant rise in awareness and demand for personalized healthcare services. Personalized medicine is an approach to healthcare that takes into account an individual's unique gene makeup and environmental factors to tailor medical treatments and interventions. Such trends are expected to increase the demand for genetic testing. Moreover, the development of NGS has accelerated the pace of accessibility and affordability of genome sequencing. Large-scale genomic investigations have been made possible by these developments, which have also made it easier to find genetic markers linked to illness and medication responses.

Growing public awareness about the gene-based screening is also expected to have positive impact on the market growth. For instance, according to the MIT Technology Review, more than 26 million people in the U.S. have already taken DNA tests. The increasing interest of the public in ancestry and genetic testing is driven by increasing advertisements in digital media and online marketing. Key market players, such as 23andMe and Ancestry, are spending heavily on the advertisement of DTC genetic testing to spread awareness about their products and benefits associated with it.

Increasing awareness campaigns regarding the benefits of genomic screening are projected to increase the uptake of cost-effective DTC genetic testing. Moreover, the involvement of market players and regulatory bodies to promote the testing and integration of these services in healthcare settings to reduce overall healthcare expenditure are supporting the market growth. Genetic testing can help manage the rising burden of various targeted diseases by reducing the need for unnecessary screening to detect life-threatening diseases. According to the survey conducted by WebMD in June 2023, most people and doctors agreed that genetic testing is important for personalized healthcare. Around 92% of the doctors said genetic information is important for the patient’s complete health picture, and it could help lead to better outcomes for patients. Moreover, in June 2020, the Australian Medical Association Limited (AMA) stated that genetic testing is likely to transform healthcare services by offering more cost-effective treatments and improving patient outcomes. Such instances are expected to fuel the demand for DTC genetic tests across the globe.